Anavex life sciences announces issuance of u.s. patent covering anavex®2-73 (blarcamesine) for neurodevelopmental disorders therapy

Issuance of anavex's newest u.s. patent will expand anavex's intellectual property portfolio surrounding anavex®2-73 issuance of anavex's newest u.s. patent will expand anavex's intellectual property portfolio surrounding anavex®2-73
AVXL Ratings Summary
AVXL Quant Ranking